SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009508
Filing Date
2024-06-26
Accepted
2024-06-26 16:30:11
Documents
14
Period of Report
2024-06-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20240621x8k.htm   iXBRL 8-K 35523
  Complete submission text file 0001558370-24-009508.txt   173464

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20240621.xsd EX-101.SCH 3510
3 EX-101.LAB glyc-20240621_lab.xml EX-101.LAB 18759
4 EX-101.PRE glyc-20240621_pre.xml EX-101.PRE 13112
17 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20240621x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 241073806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)